More on Flexion Q2 results

|About: Flexion Therapeutics, ... (FLXN)|By:, SA News Editor

Flexion Therapeutics (FLXN +1.6%) Q2 results: Revenues: $0; Net Loss: ($5.9M) (-29.0%); Loss Per Share: ($0.38) (+93.5%); Quick Assets: $72.0M (+339.0%).

No financial guidance given.